oxazoles has been researched along with Weight Gain in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 6 (50.00) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Alessio, N; Bagetta, G; Belardo, C; De Dominicis, E; Galderisi, U; Iannotta, M; Infantino, R; Luongo, L; Maione, S; Pagano, M; Palazzo, E; Perrone, M; Rinaldi, B; Scuteri, D | 1 |
Han, CL; Qu, CZ | 1 |
Kim, J; Lee, H; Park, SD; Roh, JS; Shin, SS; Woo, S; Yoon, M | 1 |
Fiedorek, FT; Rubin, CJ; Viraswami-Appanna, K | 1 |
Cano, C; Decara, JM; Fresno, N; Macias-González, M; Pavón, FJ; Pérez-Fernández, R; Rivera, P; Rodríguez de Fonseca, F; Romero-Cuevas, M; Serrano, A; Suárez, J; Vida, M | 1 |
Albert, LM; Frail, DE; Harris, HA; Henderson, RA; Keith, JC; Kharode, YP; Komm, BS; Leathurby, Y; Malamas, MS; Marzolf, J; Mewshaw, RE; Miller, CP; Winneker, RC; Zhu, Y | 1 |
Gray, LE; LeBlanc, GA; Wolf, CJ | 1 |
Cohen, HW; Etgen, AM; Jover, T; Miller, NR; Zukin, RS | 1 |
Doggrell, SA | 1 |
Brunmair, B; Fürnsinn, C; Furtmüller, R; Kühnle, HF; Meyer, M; Neschen, S; Nowotny, P; Roden, M; Schneider, B; Waldhäusl, W | 1 |
Gray, LE; LeBlanc, GA; Ostby, JS; Wolf, CJ | 1 |
Paik, IK | 1 |
1 review(s) available for oxazoles and Weight Gain
Article | Year |
---|---|
Cardiovascular Risk and Safety Evaluation of a Dual Peroxisome Proliferator-Activated Receptor-Alpha/Gamma Agonist, Aleglitazar, in Patients With Type 2 Diabetes: A Meta-analysis.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Lipids; Male; Middle Aged; Oxazoles; PPAR alpha; PPAR gamma; Risk Assessment; Risk Factors; Thiophenes; Treatment Outcome; Weight Gain | 2020 |
1 trial(s) available for oxazoles and Weight Gain
Article | Year |
---|---|
Efficacy and safety of muraglitazar: a double-blind, 24-week, dose-ranging study in patients with type 2 diabetes.
Topics: Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Edema; Female; Glycated Hemoglobin; Glycine; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Oxazoles; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Time Factors; Treatment Outcome; Weight Gain | 2009 |
10 other study(ies) available for oxazoles and Weight Gain
Article | Year |
---|---|
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation.
Topics: Adipose Tissue; Animals; Body Weight; Hyperalgesia; Male; Mice; Obesity; Oxazoles; Social Isolation; Weight Gain | 2022 |
Herbal composition Gambigyeongsinhwan (4) from Curcuma longa, Alnus japonica, and Massa Medicata Fermentata inhibits lipid accumulation in 3T3-L1 cells and regulates obesity in Otsuka Long-Evans Tokushima Fatty rats.
Topics: 3T3-L1 Cells; Alnus; Animals; Anti-Obesity Agents; CCAAT-Enhancer-Binding Proteins; Curcuma; Drugs, Chinese Herbal; Fatty Acid-Binding Proteins; Lipid Metabolism; Male; Medicine, Korean Traditional; Mice; Obesity; Oxazoles; Phytotherapy; Plant Extracts; Plant Preparations; PPAR alpha; PPAR gamma; Rats, Inbred OLETF; RNA, Messenger; Triglycerides; Tyrosine; Weight Gain | 2015 |
Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Amides; Animals; Blood Glucose; Cholesterol; Feeding Behavior; Gene Expression Profiling; Gene Expression Regulation; Glucose Tolerance Test; Humans; Hydrogen Bonding; Insulin; Insulin Resistance; Ligands; Liver; Male; Models, Molecular; Oleic Acids; Oxazoles; PPAR alpha; Protein Binding; Rats; Solutions; Sulfonamides; Taste; Thermogenesis; Tyrosine; Weight Gain | 2012 |
Evaluation of an estrogen receptor-beta agonist in animal models of human disease.
Topics: Animals; Animals, Genetically Modified; Arthritis, Experimental; beta 2-Microglobulin; Bone Density; Bone Diseases, Metabolic; Cell Line; Disease Models, Animal; Estrogen Receptor beta; Female; HLA-B27 Antigen; Humans; Inflammatory Bowel Diseases; Mammary Glands, Animal; Mice; Ovariectomy; Oxazoles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Receptors, Estrogen; Uterus; Weight Gain | 2003 |
Interactive effects of vinclozolin and testosterone propionate on pregnancy and sexual differentiation of the male and female SD rat.
Topics: Abnormalities, Drug-Induced; Androgen Antagonists; Animals; Animals, Newborn; Birth Weight; Body Weight; Female; Fetal Viability; Fetus; Genitalia; Male; Organ Size; Oxazoles; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Sex Characteristics; Sex Differentiation; Sexual Maturation; Teratogens; Testosterone Propionate; Weight Gain | 2004 |
Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death.
Topics: Animals; Brain Ischemia; Cell Survival; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Feedback, Physiological; Female; Hippocampus; Lordosis; Luteinizing Hormone; Neurons; Neuroprotective Agents; Oxazoles; Phenols; Pyrazoles; Rats; Rats, Sprague-Dawley; Time Factors; Weight Gain | 2005 |
Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes?
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycine; Humans; Hypoglycemic Agents; Middle Aged; Oxazoles; Randomized Controlled Trials as Topic; Research Design; Weight Gain | 2006 |
Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism.
Topics: Animals; Biological Transport; Body Weight; Cell Line; Deoxyglucose; Glucose; In Vitro Techniques; Insulin; Ligands; Male; Muscle, Skeletal; Obesity; Oxazoles; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Thiazoles; Thiazolidinediones; Transcription Factors; Weight Gain | 1999 |
Characterization of the period of sensitivity of fetal male sexual development to vinclozolin.
Topics: Androgen Antagonists; Animals; Embryonic and Fetal Development; Female; Fertility; Fungicides, Industrial; Genitalia, Male; Male; Organ Size; Oxazoles; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Long-Evans; Sexual Maturation; Testis; Weight Gain | 2000 |
Nutritional value of processed rapeseed meal.
Topics: Amino Acids; Ammonia; Animal Feed; Animals; Antithyroid Agents; Brassica; Chickens; Eating; Energy Intake; Energy Metabolism; Fatty Acids, Monounsaturated; Food Handling; Hydrolysis; Iodine; Isothiocyanates; Male; Minerals; Nutritive Value; Organ Size; Oxazoles; Oxazolidinones; Plant Oils; Rapeseed Oil; Rats; Thiocyanates; Weight Gain | 1991 |